Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
MSD Animal Health has strengthened its UK market by opening a new manufacturing, packaging and warehousing facility in Milton Keynes.
US-based Tiba Biotech has developed a platform technology for the rapid production of self-replicating mRNA vaccines that can be programed to protect against multiple pathogens.
Subscribers have five weeks to nominate their company and their innovations in the Animal Pharm Awards for 2018.
Chinese firm Pulike Biological Engineering is building a stronger platform for long-term sales growth.
ECO-Pharm is to bring its swine vaccines to the Japanese and Brazilian markets.
Researchers from the University of Helsinki have created the first vaccine for insects – PrimeBEE – to fight against microbial diseases that can be detrimental to pollinator communities.
CZ Veterinaria is changing its name to CZ Vaccines – coinciding with the 25th anniversary of the biotech company's founding.
Chinese company Foshan Standard Bio-tech is looking for partners to take its poultry coccidiosis vaccine to the global market.
Scientists at the Roslin Institute and the Pirbright Institute claim a new vaccine strategy could give protection to millions of chickens against infectious bronchitis virus (IBV).
Hysolv Animal Health has launched a flu vaccine for pigs developed by IDT Biologika in the UK and Ireland.
The Pirbright Institute has conducted the first study that directly compares the ability of two peste des petits ruminants (PPR) vaccines to protect animals against wildtype viruses from any of the four genetic lineages of PPR virus.
At a time when veterinary vaccine development is under a microscope due to the growing presence of African swine fever (ASF), Animal Pharm editor Joseph Harvey spoke to Gwynneth Clay – senior project manager of the Brucellosis Vaccine Prize initiative at the Global Alliance for Livestock Veterinary Medicines (GALVmed) – to find out how this project is stimulating R&D in an underserved area.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.